These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9457289)

  • 1. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum.
    Björk T; Ljungberg B; Piironen T; Abrahamsson PA; Pettersson K; Cockett AT; Lilja H
    Urology; 1998 Jan; 51(1):57-62. PubMed ID: 9457289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H; Haese A; Björk T; Friedrich MG; Piironen T; Pettersson K; Huland E; Huland H
    J Urol; 1999 Dec; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.
    Stephan C; Jung K; Brux B; Lein M; Sinha P; Schnorr D; Loening SA
    Urology; 2000 Apr; 55(4):560-3. PubMed ID: 10736503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
    Gregorakis AK; Malovrouvas D; Stefanakis S; Petraki K; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):196-201. PubMed ID: 15936010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free/total prostate-specific antigen ratio--hope and controversies.
    Ravery V; Boccon-Gibod L
    Eur Urol; 1997; 31(4):385-8. PubMed ID: 9187894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy.
    Richardson TD; Wojno KJ; Liang LW; Giacherio DA; England BG; Henricks WH; Schork A; Oesterling JE
    Urology; 1996 Dec; 48(6A Suppl):40-4. PubMed ID: 8973698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.
    Piironen T; Pettersson K; Suonpää M; Stenman UH; Oesterling JE; Lövgren T; Lilja H
    Urology; 1996 Dec; 48(6A Suppl):81-7. PubMed ID: 8973706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing.
    Piironen T; Nurmi M; Irjala K; Heinonen O; Lilja H; Lövgren T; Pettersson K
    Clin Chem; 2001 Apr; 47(4):703-11. PubMed ID: 11274021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Custovic Z; Kraus O; Tomaskovic I; Tarle M
    Anticancer Res; 2007; 27(4C):2817-21. PubMed ID: 17695453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
    Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
    Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.
    Birkenmeier G; Struck F; Gebhardt R
    J Urol; 1999 Sep; 162(3 Pt 1):897-901. PubMed ID: 10458404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer.
    Björk T; Piironen T; Pettersson K; Lövgren T; Stenman UH; Oesterling JE; Abrahamsson PA; Lilja H
    Urology; 1996 Dec; 48(6):882-8. PubMed ID: 8973671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y; Okamura K; Takamura S; Okamoto N; Narishima M; Yoshino Y; Hattori R; Ono Y; Ohshima S; Nagasaka T
    Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technicon Immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis.
    Zhou Z; Ng PC; Very DL; Allard WJ; Yeung KK
    J Clin Lab Anal; 1996; 10(3):155-9. PubMed ID: 8731504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy.
    Stephan C; Jung K; Brux B; Lein M; Sinha P; Schnorr D; Loening SA
    Clin Chem Lab Med; 2000 Apr; 38(4):309-11. PubMed ID: 10928650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
    Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
    Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors.
    Coker CB; Coptcoat MJ; Mulvin D; Cuomo A; Scott N; Sherwood R
    Br J Urol; 1998 Jan; 81(1):105-8. PubMed ID: 9467485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
    Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.